FDA Approved: ETHACRYNIC ACID — Original Application (ScieGen Pharmaceuticals Inc)

View source ↗

Summary

FDA approved Ethacrynic acid from ScieGen Pharmaceuticals Inc under an Original Application (ANDA211232).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Edema
• Heart Failure
• Hepatic Cirrhosis
• Nephrotic Syndrome

Drugs mentioned

• ETHACRYNIC ACID (Ethacrynic acid)

Snippet

ORIG AP for ETHACRYNIC ACID (ETHACRYNIC ACID)